Skip to contentS
Sensus Healthcare, Inc.
S
SRTSSensus Healthcare, Inc. Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$13.03M$13.03Mderived+155.6% vs Q4 2020 Net Income$5.32M$5.32Mderived+422.2% vs Q4 2020 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sensus Healthcare, Inc. · CIK 1494891 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$8,856,000+174.3% Operating Incomederived$5,319,000+1,966.8% Operating Cash Flowderived-$1,780,000N/M Free Cash Flowderived-$1,818,000N/M Margins · derivedGross margin68.0%+4.6 pt vs Q4 2020
Operating margin40.8%+35.8 pt vs Q4 2020
Net margin40.8%+20.8 pt vs Q4 2020
ended Dec 31, 2021 · filed Mar 25, 2022 · 84 d after period end